• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子(CCR)和 fractalkine(CX3CR)受体与终末期肾病。

Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease.

机构信息

Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, UP, 226014, India.

出版信息

Inflamm Res. 2011 Apr;60(4):399-407. doi: 10.1007/s00011-010-0284-3. Epub 2010 Dec 4.

DOI:10.1007/s00011-010-0284-3
PMID:21132346
Abstract

OBJECTIVE AND DESIGN

Genetic polymorphisms of chemokines and their receptors were reported to be independent risk factors for inflammation associated disease. We explored the role of CCR5-Δ32, CCR5-G59029A, CX3CR1 V249I and T280M gene polymorphisms as susceptibility for end stage renal disease (ESRD).

SUBJECTS AND METHODS

We genotyped 258 ESRD and 569 healthy controls by sequence-specific primers and RFLP and examined their association.

RESULTS

There was significant difference in genotype frequencies of CCR5-G59029A (p = 0.005), and CX3CR1 V249I (p < 0.0001) between ESRD and controls. No homozygous individuals were observed for CCR5-Δ32. The haplotype analysis of all four studied genes reveled that haplotype +/A/T/I was more significant in patients and associated with higher risk (OR = 2.95) of ESRD. Further, the haplotype of CX3CR1 (T280M, V249I) gene showed 3.6-fold higher in an individual carrying T/I haplotype. No risk was seen for CCR5 haplotypes.

CONCLUSIONS

These results highlight the role of CCR5 and CX3CR1 in ESRD.

摘要

目的和设计

趋化因子及其受体的遗传多态性被报道为与炎症相关疾病的独立危险因素。我们探讨了 CCR5-Δ32、CCR5-G59029A、CX3CR1 V249I 和 T280M 基因多态性作为终末期肾病(ESRD)易感性的作用。

受试者和方法

我们通过序列特异性引物和 RFLP 对 258 名 ESRD 和 569 名健康对照者进行了基因分型,并检测了它们的相关性。

结果

ESRD 组和对照组之间 CCR5-G59029A(p = 0.005)和 CX3CR1 V249I(p < 0.0001)的基因型频率存在显著差异。未观察到 CCR5-Δ32 的纯合个体。对所有四个研究基因的单倍型分析表明,+/A/T/I 单倍型在患者中更为显著,与 ESRD 的更高风险(OR = 2.95)相关。此外,携带 T/I 单倍型的个体中 CX3CR1(T280M,V249I)基因的单倍型增加了 3.6 倍。CCR5 单倍型没有风险。

结论

这些结果强调了 CCR5 和 CX3CR1 在 ESRD 中的作用。

相似文献

1
Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease.趋化因子(CCR)和 fractalkine(CX3CR)受体与终末期肾病。
Inflamm Res. 2011 Apr;60(4):399-407. doi: 10.1007/s00011-010-0284-3. Epub 2010 Dec 4.
2
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.趋化因子fractalkine在克罗恩病中的表达增加以及趋化因子受体T280M多态性与纤维狭窄性疾病表型的关联。
Am J Gastroenterol. 2006 Jan;101(1):99-106. doi: 10.1111/j.1572-0241.2005.00361.x.
3
Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.慢性肾衰竭血液透析患者中趋化因子受体(CX3CR1)和CCR5基因变异与高血压、糖尿病及动脉粥样硬化的相关性
Int Urol Nephrol. 2016 Jul;48(7):1163-70. doi: 10.1007/s11255-016-1293-0. Epub 2016 Apr 27.
4
Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease.印度北部终末期肾病患者的细胞因子(IL-10 -1082和-819)及趋化因子受体(CCR2和CCR5)基因多态性
DNA Cell Biol. 2009 Apr;28(4):177-83. doi: 10.1089/dna.2008.0822.
5
Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.CX3CR1受体多态性V249I和T280M对急性冠状动脉综合征发展的相反影响。趋化因子在炎症激活中的可能作用。
Thromb Haemost. 2005 May;93(5):949-54. doi: 10.1160/TH04-11-0735.
6
Distribution of human chemokine (C-X3-C) receptor 1 (CX3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression.中国人趋化因子(C-X3-C)受体1(CX3CR1)基因多态性及CC趋化因子受体5(CCR5)启动子单倍型的分布,以及CCR5单倍型对CCR5表达的影响。
Int J Immunogenet. 2005 Apr;32(2):99-106. doi: 10.1111/j.1744-313X.2005.00498.x.
7
Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.趋化因子受体CX3CR1基因多态性V249I和T280M在无经典危险因素患者早发冠状动脉疾病中作为危险因素的作用。
Scand J Clin Lab Invest. 2008;68(4):286-91. doi: 10.1080/00365510701697390.
8
Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection.趋化因子受体基因的序列变异与HIV-1感染易感性
J Appl Genet. 2009;50(2):159-66. doi: 10.1007/BF03195668.
9
Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.希腊人群中CX3CR1基因V249I和T280M多态性与帕金森病风险之间不存在关联。
Genet Test Mol Biomarkers. 2012 Aug;16(8):974-7. doi: 10.1089/gtmb.2011.0330. Epub 2012 Jun 29.
10
Polymorphism in chemokine receptor genes and risk of acute myocardial infarction in North Indian population.趋化因子受体基因多态性与北印度人群急性心肌梗死的风险。
Mol Biol Rep. 2012 Mar;39(3):2753-9. doi: 10.1007/s11033-011-1031-8. Epub 2011 Jul 10.

引用本文的文献

1
Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? fractalkine (CX3CL1)及其受体 CX3CR1:慢性肾脏病的有前途的治疗靶点?
Front Immunol. 2021 Jun 7;12:664202. doi: 10.3389/fimmu.2021.664202. eCollection 2021.
2
CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients.埃及患者中CX3CR1基因V249M和T280M位点的基因多态性及其与终末期肾病的潜在风险
Int J Nephrol. 2021 Apr 24;2021:6634365. doi: 10.1155/2021/6634365. eCollection 2021.
3
Association of Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure.

本文引用的文献

1
Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.CCR5基因-59029A/G多态性及CCL3L1基因拷贝数多态性与印度北部HIV-1血清阳性及反复性接触暴露的HIV-1血清阴性个体中HIV-1传播/进展的相关性
AIDS Res Hum Retroviruses. 2009 Nov;25(11):1149-56. doi: 10.1089/aid.2008.0019.
2
Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.肾移植中供体与受体对急性排斥易感性的遗传相互作用:CCR5基因多态性
Nephrol Dial Transplant. 2009 Sep;24(9):2919-25. doi: 10.1093/ndt/gfp317. Epub 2009 Jun 26.
3
基因多态性与衰竭患者的 fractalkine、 fractalkine 受体和 C 反应蛋白水平的关联。
Int J Environ Res Public Health. 2021 Feb 23;18(4):2202. doi: 10.3390/ijerph18042202.
4
Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.趋化因子受体CX3CR1 V249I和T280M基因多态性与慢性肾脏病的关联
Indian J Nephrol. 2016 Jul-Aug;26(4):275-9. doi: 10.4103/0971-4065.163426.
5
Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.慢性肾衰竭血液透析患者中趋化因子受体(CX3CR1)和CCR5基因变异与高血压、糖尿病及动脉粥样硬化的相关性
Int Urol Nephrol. 2016 Jul;48(7):1163-70. doi: 10.1007/s11255-016-1293-0. Epub 2016 Apr 27.
6
Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients.中国肾移植受者中RAC1基因多态性与原发性终末期肾病的关联
PLoS One. 2016 Feb 3;11(2):e0148270. doi: 10.1371/journal.pone.0148270. eCollection 2016.
7
Expression of chemokine receptors on peripheral blood T cells in children with chronic kidney disease.慢性肾脏病患儿外周血T细胞趋化因子受体的表达
Mediators Inflamm. 2015;2015:536894. doi: 10.1155/2015/536894. Epub 2015 Mar 18.
CCR5 deletion protects against inflammation-associated mortality in dialysis patients.CCR5基因缺失可预防透析患者因炎症导致的死亡。
J Am Soc Nephrol. 2009 Jul;20(7):1641-9. doi: 10.1681/ASN.2008040432. Epub 2009 Apr 23.
4
Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease.印度北部终末期肾病患者的细胞因子(IL-10 -1082和-819)及趋化因子受体(CCR2和CCR5)基因多态性
DNA Cell Biol. 2009 Apr;28(4):177-83. doi: 10.1089/dna.2008.0822.
5
Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.斯洛伐克人群中人类免疫缺陷病毒1型共受体CCR5基因32碱基对缺失的患病率。
Acta Virol. 2008;52(4):261-4.
6
Molecular pathology of age-related macular degeneration.年龄相关性黄斑变性的分子病理学
Prog Retin Eye Res. 2009 Jan;28(1):1-18. doi: 10.1016/j.preteyeres.2008.10.001. Epub 2008 Nov 6.
7
Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.RANTES启动子变体与CCR5Delta32之间的相互作用有利于乙型肝炎的康复。
J Immunol. 2008 Dec 1;181(11):7944-7. doi: 10.4049/jimmunol.181.11.7944.
8
Chemokines in atherosclerosis: an update.动脉粥样硬化中的趋化因子:最新进展
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1897-908. doi: 10.1161/ATVBAHA.107.161174. Epub 2008 Jun 19.
9
The CCR5 32-bp deletion allele is rare in a Chinese population.CCR5基因32碱基对缺失等位基因在中国人群中较为罕见。
Schizophr Res. 2008 Apr;101(1-3):341-3. doi: 10.1016/j.schres.2008.01.015. Epub 2008 Mar 4.
10
CCR5 receptor: biologic and genetic implications in age-related diseases.CCR5受体:在与年龄相关疾病中的生物学和遗传学意义
Ann N Y Acad Sci. 2007 Apr;1100:162-72. doi: 10.1196/annals.1395.014.